Inox Wind bagged repeat orders from the Malpani Group and top corporate news of the day

India Infoline News Service | Mumbai | October 14, 2016 08:51 IST

Check out the most important news stories which captured the headlines at the corporate level in India and internationally.

Jubilant Life Sciences has received the final approval from the US health regulator for Darifenacin Extended-Release Tablets, used for the treatment of urinary incontinence. (BL)
Inox Wind has bagged repeat orders from the Malpani Group for 40MW wind power projects in Gujarat. (BL)
Granules has received approval from the US health regulator for anti-inflammatory drug Ibuprofen tablets, in the US market. (BS)
Bharti Airtel has relaunched its MyAirtel app with new ‘Airtel Apps’ section that will have a collection of top apps under a single interface, in addition to the existing selfcare features. (ET)

Dr Reddy's Laboratories has launched Aripiprazole tablets in 2mg, 5mg, 10mg, and 30mg, a therapeutic equivalent generic version of Ablify tablets in the US market following the approval from the US Food and Drug Administration (USFDA). (BS)
Coal India has tied up with Andhra Pradesh Generation Company (APGenco) for substituting imported fuel, used for blending purposes, by high quality Ranigunj coal. The initiative is part of the CIL’s effort to market Ranigunj coal that has few takers. (BL)
As it looks to take on Reliance Jio heads on in providing high-speed broadband internet services, Bharti Airtel has deployed a technology that will deliver speeds of up to 100Mbps on its fixed broadband footprint in 87 cities. (BS)
Reliance Broadcast Network is in advanced talks with the Zee Entertainment Enterprises (ZEEL). The deal is expected to be in the range of Rs18-20bn. (BS)



  • Save upto Rs.2.67 lakh with Pradhan Mantri Awas Yojana ...Know more
  • Now Save Rs.3150 on your Demat Account ...Click here
  • Now get IIFL Personal Loan in just 8* hours...APPLY NOW!
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.